2024 annual financial data
Keros Therapeutics 2024 Operating margin
Direct answer
Operating margin was -5,938.96%.
Operating income was -210,833,000 USD and net income was -187,353,000 USD.
Operating cash flow was -160,869,000 USD.
Get free Keros Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,550,000 USD
- Operating income
- -210,833,000 USD
- Net income
- -187,353,000 USD
- Operating cash flow
- -160,869,000 USD